The two companies plan a single imaging pathway that carries a brain-computer interface patient from candidacy scan to post-surgical check.
FastGlioma scored tumor infiltration in unprocessed surgical samples and predicted the sites of first recurrence.
Quicktome Deep Brain becomes the Sydney company's third FDA clearance, extending its brain-network platform into deep brain stimulation.
A London hospital says live AI analysis of camera footage helped surgeons remove a brain tumor while sparing a patient's…
Vancouver police sergeant Lee Marten can control his phone and laptop with his thoughts after Neuralink surgery in Toronto.